The TSX Venture Exchange has accepted for filing the documentation relating to an arm's-length subscription of a $4-million secured convertible debenture of Tricho-Med Corp., with an annual interest rate of 10 per cent and a four-year maturity, convertible into a 49-per-cent interest in Tricho-Med and a 5-per-cent royalty on Tricho-Med's net sales.
For further information, please refer to the company's news releases dated Oct. 31, 2017, and Jan. 8, 2018.
© 2024 Canjex Publishing Ltd. All rights reserved.